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Pentamidine  isethionate  (PNT)  is  an  antiprotozoal  active  in  many  cases  of  leishmaniasis,  despite  the
present  limitations  including  high  toxicity  and  parenteral  administration.  In the present  work,  a  PNT
encapsulation  strategy  into  -cyclodextrin  cavity  at 1:1  and  2:1  (CD:PNT)  molar  ratios  was  used  in
order  to improve  the  drug’s  physical  and  chemical  properties.  Combining  thermodynamic  and  structural
approaches  such  as  isothermal  titration  calorimetry  (ITC),  electrospray  ionization  mass  spectrometry
(ESI-MS)  and  nuclear  magnetic  resonance  (1H  NMR,  and  ROESY)  the inclusion  process  and  the  ther-upramolecular complex
-cyclodextrin
entamidine
ulti-equilibrium
eishmaniasis
modynamics  parameters  were  identiﬁed.  ITC  and  ESI-MS  experimental  data suggest the  simultaneous
formation  of  different  supramolecular  complexes  in solution.  Moreover,  NMR  data  are  in accordance  with
these  results,  suggesting  a deep  inclusion  of PNT  into  the  CD  cavity,  through  correlations  observed  in 2D
ROESY  contour  maps.  The  systems  were  also  characterized  by  FTIR,  TG/DTA  and  SEM. These  techniques
indicate  the  formation  of  inclusion  complex  in  the  solid  state.  In vivo  PNT  activity  was  evaluated  orally
plexn  vivo experiments in  mice.  The  inclusion  com
. Introduction
Leishmaniasis is one of the most neglected tropical diseases
hich is caused by an intracellular protozoan parasite belonging
o the genus Leishmania (Akopyants et al., 2009). Chemotherapy
f infected patients with Leishmaniasis still represents a serious
roblem, as the treatment options are very limited (Croft et al.,
005; Murray et al., 2005). The ﬁrst choice drugs for treatment
re based on pentavalent antimony, however, these have limited
fﬁcacy and signiﬁcant toxicity (Nakayama et al., 2005). In partic-
lar, 1,5-bis(4-amidinophenoxy)pentane isethionate, Pentamidine
PNT) depicted in Fig. 1a ﬁrst synthesized in the 40s (Ashley et al.,
942), is a well known aromatic diamidine with antiprotozoan
ctivity. PNT is commonly used as second-line antileishmanial drug
Nacher et al., 2001; Croft and Yardley, 2002) and is most recom-
ended in case of antimonial resistant (Croft and Yardley, 2002;
akayama et al., 2005) or, more recently, in cases of cross-infection
ith HIV (Manfredi et al., 2008). An important feature of this drug
s based on the fact that at physiological pH the amidine groups
re protonated, which decreases the drug’s permeability, thereby
∗ Corresponding author. Tel.: +55 32 2102 3310; fax: +55 32 2102 3314.
E-mail  address: ﬂavia.machado@ufjf.edu.br (F.C. Machado).
378-5173 © 2012 Elsevier B.V.   
ttp://dx.doi.org/10.1016/j.ijpharm.2012.09.039
Open access under the Elsevier OA license. showed  a signiﬁcant  reduction  of parasite  load  compared  to  free PNT.
© 2012 Elsevier B.V. 
reducing its oral activity (Docampo and Moreno, 2003). Thus, PNT
requires a parenteral administration, which makes the treatment
less practical, especially in more isolated areas, where treatment
access is difﬁcult (Nakayama et al., 2005).
PNT is well tolerated by most patients in spite of some
reported adverse effects, including nephrotoxicity, hepatotoxic-
ity and hypotension (Puckowska et al., 2004; Nakayama et al.,
2005; Zolek and Maciejewska, 2010). These adverse effects associ-
ated with the increasing resistance of the protozoa to PNT require
sophisticated approaches to delivery of this class of drugs. Efﬁ-
cient alternatives include chemical modiﬁcation to obtain drug
analogues or using modiﬁed drug delivery systems. In particu-
lar, molecular encapsulation has been applied to many classes of
drugs and the observed results have been promising, indicating an
improvement in the physical, chemical and biological properties of
the included molecules (Marques et al., 2011; Passos et al., 2011).
Previous works have reported the PNT encapsulation in liposomes
(Banerjee et al., 1996; Siddiqui et al., 2009) and nanoparticles (Paul
et al., 1997, 1998) in order to increase tolerance and to reduce draw-
backs. Particularly, drug encapsulation into cyclodextrins (CDs)
Open access under the Elsevier OA license.cavities is an interesting alternative that has been applied to a vari-
ety of guest drugs, being these macromolecules good candidates for
sophisticated drug delivery systems (De Sousa et al., 2010; Ivana
Lula et al., 2011).
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ichiometric ratios were investigated by ESI-MS. This technique hasFig. 1. Schematic structure of (a) Pentamidine isethionate and (b) -cyclodextrin.
It is well known that CDs are cyclic oligosaccharides with a
runcated cone shape as shown in Fig. 1b, formed by 6, 7, or 8
lucopyranose units linked by -1,4-glycosidic bond, respectively
amed as -, -, or -cyclodextrin. The polar hydroxyl groups
ocated on the molecule’s border confer water solubility, while,
heir hydrophobic cavity allows them to host a variety of “guest”
olecules, forming inclusion complexes (ICs) which are stabi-
ized by non covalent interactions, this amphiphilic character being
he main characteristic of CDs (Szejtli, 1998; Wenz et al., 2006).
Ds are used as multi-functional pharmaceutical excipients due to
heir special ability to complex drugs, modifying their properties
uch solubility, stability, bioavailability and toxicity (Loftsson et al.,
005; Brewster and Loftsson, 2007; Carrier et al., 2007).
It has been previously described in the literature that in aque-
us solutions, CDs and their ICs are able to self-assemble, forming
uperstructures (Messner et al., 2010; De Sousa et al., 2012). CDs
an assemble into different aggregates under speciﬁc condition (He
t al., 2008), which are in dynamic equilibrium with free molecules
Duan et al., 2005), these assembled structures being stabilized by
ydrophobic, van der Waals, hydrogen bonding, and electrostatic
nteractions (Lehn, 2002). Since not only a host–guest interactions
ould need to be broken, but a large number hydrogen bonding
nd other attractive forces should be disrupted to release the drug
olecule, being assembled superstructures an additional reason
or the modiﬁed drug release proﬁle (Chen and Liu, 2010; De Sousa
t al., 2012). In this sense, several physical-chemical techniques
ave been used in order to identify these assembled superstruc-
ures in the presence and absence of guest molecules, correlating
ystem size, structure, morphologies and biological activity of the
rugs (Duan et al., 2005; He et al., 2008; Chen and Liu, 2010;
essner et al., 2010; De Sousa et al., 2012).
Therefore, the aim of this study is to investigate the inclusion
f PNT into the CD cavity and the inﬂuence of the host molecule
oncentration in the supramolecular structure and assembly prop-
rties. Additionally, the inclusion process in CD can turn PNT
ctive by oral administration resulting in a feasible and accessible
reatment. ICs were characterized by isothermal titration calorime-
ry (ITC), electrospray ionization-mass spectrometry (ESI-MS)
nd nuclear magnetic resonance (uni and bi-dimensional experi-
ents). PNT inclusion was also characterized in the solid state by
ourier transform infrared spectroscopy (FTIR), thermal analysis
TG and DTA) and scanning electron microscopy (MEV). In order tof Pharmaceutics 439 (2012) 207– 215
evaluate our assumptions about the CDs superstructures, orally
in vivo experiments were performed to verify the antileishmanial
activity of the included drug.
2. Materials and methods
2.1. Reagents and inclusion compounds preparation
PNT and CD were obtained from Sigma Aldrich and Roquette,
respectively. All ICs were prepared by a freeze-drying method at
1:1, 2:1, 3:1 and 4:1 molar ratios of CD:PNT. In this method, an
aqueous solution (50 mL)  containing PNT (1.69 × 10−3 mol/L for all
molar ratios) and CD (1.69 × 10−3, 3.37 × 10−3, 5.06 × 10−3and
6.74 × 10−3 mol/L for 1:1, 2:1, 3:1 and 4:1 molar ratios of CD:PNT,
respectively) was stirred for 8 h to ensure that equilibrium had been
obtained. The resulting solution was frozen in liquid nitrogen and
lyophilized for 72 h to obtain the solid ICs. In order to compare the
results in the solid state, physical mixtures (PMs) were prepared in
the same molar ratios of those ICs, PM-CD:PNT (1:1), PM-CD:PNT
(2:1), PM-CD:PNT (3:1) and PM-CD:PNT (4:1).
2.2. Isothermal titration calorimetry experiments
Calorimetric titrations were performed in a VP-ITC
Microcalorimeter (Microcal Company, Northampton, MA,  USA) at
25 ◦C. Each titration experiment consisted of 50 successive injec-
tions of PNT aqueous solution (30.0 mmol  L−1) into the reaction cell
loaded with 1.5 mL  of a CD aqueous solution (1.0 mmol L−1), with
time intervals of 230 s, which were sufﬁciently long for the signal
to return to the baseline. The ﬁrst injection of 1 L was discarded
to eliminate diffusion effects of material from the syringe in the
calorimetric cell. Subsequent injections of constant volume of 5 L
of PNT were carried out with an injection time of 5 s. PNT heat of
dilution was  studied in the control experiment to be subsequently
subtracted from the heat reaction measured in the titration of PNT
in CD aqueous solution, to achieve the net heat of reaction.
Data were collected automatically and subsequently analyzed
by the software package supplied by the calorimeter (Microcal
Origin 5.0 for ITC). Stoichiometry (N), binding constant (K) and
enthalpic contribution (H◦) were obtained by nonlinear ﬁtting
incorporated in the software (one binding site model). From these
results, the change in Gibbs standard free energy (G◦) was  calcu-
lated using the binding constant and the entropic contribution was
subsequently calculated.
2.3. Nuclear magnetic resonance experiments
NMR  spectra were recorded at 27 ◦C in a Bruker DRX 400
AVANCE spectrometer (Bruker BioSpin, Rheinstetten, Germany)
operating at 400 MHz, equipped with a 5 mm inverse probe with
a z-gradient coil. 1H NMR  spectra were acquired using the WATER-
GATE technique for residual water signal suppression (Piotto et al.,
1992; Sklenar et al., 1993). Nuclear rotating frame Overhauser
enhancement spectroscopy (2D ROESY) experiments (mixing time
400 ms)  were acquired using standard experiments from the spec-
trometer library. PNT and its ICs at all molar ratios were dissolved in
D2O (Cambridge Isotope Laboratories, Inc. 99.9% of isotopic purity).
2.4. Electrospray ionization mass spectrometry (ESI-MS)
The anti-leishmanial PNT and its ICs with various PNT:CD sto-been applied to study similar systems (Martins et al., 2006; Denadai
et al., 2007) providing insights about the supramolecular structure
of the ICs, including the assembly process and stoichiometry.
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ESI-MS analyses were conducted using an MS instrument
model LCQ-Fleet, Thermo-Scientiﬁc, San Jose, CA, USA) coupled
o an ion trap analyzer and operating in the positive ion mode.
liquots of 500 L aqueous solutions were directly injected within
he ion source by means of a microsyringe. The concentration
f PNT analyzed was 0.0127 mol/L and of ICs were 5.83 × 10−3,
.50 × 10−3, 2.53 × 10−3 and 2.11 × 10−3 mol/L for 1:1, 2:1, 3:1 and
:1 molar ratios of CD:PNT, respectively. Typical conditions were
sed as follow: microsyringe ﬂow rate of 20 L min−1; capillary
emperature of 275 ◦C; capillary and cone voltages 16 V and of 5 kV,
espectively. Each mass spectrum, acquired in the m/z range of
0–2000, was obtained as an average of 50 scans, each one requiring
.1 s.
.5. Fourier transform infrared spectroscopy (FTIR)
Infrared spectra were obtained with a Bomen MB-102 spectrom-
ter using KBr pellets in the wavenumber range of 4000–400 cm−1
t a resolution of 4 cm−1. Good signal-to-noise ratios were obtained
rom accumulation of 64 scans.
.6. Thermal analysis (TG and DTA)
Thermogravimetric analysis (TG) and differential thermal anal-
sis (DTA) were executed on a TA instruments SDT Q600 using a
itrogen gas purge atmosphere at 50 mL  min−1 and a heating rate of
0 ◦C min−1. All compounds (about 6 mg)  were analyzed in a range
rom 25 to 700 ◦C in an open alumina pan (Al2O3) and an empty alu-
ina pan was used as reference. DTA curves of free molecules, PMs
nd ICs were obtained simultaneously with the TG experiments.
.7. Scanning electron microscopy (SEM)
Morphologies of CD, PNT, PMs  and ICs, coated with thin gold
ayer, were analyzed using scanning electron microscopy in a JEOL,
od JSM 840A microscope, operating at 4–10 kV.
.8. In vivo experiments
.8.1. Parasites
Leishmania (L.) infantum chagasi (MHOM/BR/70/BH46) parasites
ere routinely maintained and isolated from Golden Syrian ham-
ters (Mesocricetus auratus) and were grown as promastigotes at
6 ◦C in Dulbecco Modiﬁed Eagle medium (DMEM, Sigma), supple-
ented with 20% heat-inactivated fetal bovine serum (FBS, Cultilab,
razil), 2 mmol  L−1 l-glutamine, 25 mmol  L−1 HEPES, 50 mmol  L−1
-mercaptoethanol and 20 mg  mL−1 of gentamycin, at pH 7.0.
.8.2. Mice infection and treatment protocol
BALB/c mice (female, 4–6 week-old) were obtained from Cebio
Centro de Bioterismo do Instituto de Ciências Biológicas, Universi-
ade Federal de Minas Gerais). Free access was allowed to standard
iet and tap water was supplied ad libitum.
Groups of mice (n = 7–10) were infected in the tail vein with
 × 106 of late log phase L. (L.) infantum chagasi promastigotes. The
reatment was  started 8 days after infection with daily doses for 20
ays. The different formulations administered by gavage with doses
f 200 L, to mice of ﬁve groups, was as follows: the ﬁrst group was
reated with free PNT in a dose of 50 mg/kg (8.85 × 10−3 mol/L),
he second group with the CD:PNT at 1:1 (9.43 × 10−3 mol/L) in
 dose of 145 mg/kg (which contains the same mass of the free
rug used in the ﬁrst group), the third was treated with free CD
8.02 × 10−3 mol/L) at a dose of 95 mg/kg (same dosage of CD
resented in the IC at 1:1) and a fourth group was  treated with
aline (negative control). A ﬁfth group used as positive control,f Pharmaceutics 439 (2012) 207– 215 209
received the commercial antimonial drug Glucantime® (Sanoﬁ-
Aventis, São Paulo, Brazil), intraperitoneally at 80 mg/kg. All groups
were treated daily and after 21 days, the animals were sacriﬁced
and the spleen and liver were harvested for determination of par-
asite burdens.
Experimental protocols were performed in accordance with the
guidelines for the humane use of laboratory animals and received
approval from the Ethics Committee in Animal Experimentation of
the Federal University of Minas Gerais (protocol no. 199/2011).
2.8.3. Parasite quantiﬁcation
Liver and spleen were collected to determine the parasite bur-
dens in mice challenged with L. chagasi, as previously described
(Marques-da-Silva et al., 2005). Brieﬂy, organs were weighed, frag-
mented and a tissue homogenate was obtained in 1 mL  of DMEM
plus 20% FBS, at pH 7.0. Five-fold serial dilutions were performed
in 96-well ﬂat-bottom microtiter plates (Nunc, Nunclon), in dupli-
cate, and plates were incubated at 23 ◦C. Plates were evaluated for
parasite growth using a microscope (Axiovert 25, Zeiss). The num-
ber of viable parasites was determined from the highest dilution at
which promastigotes had grown, after 12 days of incubation.
3. Results and discussion
3.1. Isothermal titration calorimetry
ITC is a powerful technique to study the complexation process
in supramolecular systems. Thus, it was  used in order to evaluate
the thermodynamic parameters of the supramolecular interaction
between PNT and CD. Fig. 2a shows the PNT titration in water
(control experiment) and in CD aqueous solution while Fig. 2b
shows the heat of reaction measured in the titration of PNT in CD
aqueous solution, after subtracting the heat of dilution of PNT in
water.
PNT dilution experiment in water demonstrates a slightly
exothermic proﬁle (Fig. 2a), which can be correlated with the disso-
ciation of the PNT molecules in the reaction cell. The PNT titration
curve in CD provides negative heat of reaction values, indicating
an exothermic process, as observed in Fig. 2b. This exothermic pro-
ﬁle can be attributed to the host–guest interactions as described
for similar systems (Denadai et al., 2007; De Sousa et al., 2008b).
This curve was ﬁtted using the nonlinear adjustment based on
the Wiseman isotherm (Turnbull and Daranas, 2003), providing
the stoichiometric coefﬁcient (N) equivalent to 0.84 ± 0.01, the
equilibrium constant K = 758 ± 7 and the enthalpy contribution
H◦ = −11.2 ± 0.2 kJ mol−1. Furthermore, the PNT:CD IC forma-
tion process was  spontaneous as evidenced by the Gibbs standard
free energy G◦ (−16.4 kJ mol−1). Additionally, a positive entropic
contribution (TS◦ = 5.2 kJ mol−1) was calculated.
Complexation thermodynamic parameters reﬂect the nature
of non covalent interactions occuring between guest and host
molecules. The ICs formation is primarily a result of hydrophobic
interactions between the guest molecule and the host’s rela-
tively hydrophobic cavity; therefore, it is driven by the enthalpic
contribution. Enthalpy change can be associated with the water
molecules exit from the CD cavity to accommodate the PNT
molecule and the formation of supramolecular cooperative inter-
actions between the drug and the host molecule. The desolvation
of CD and PNT during the complexation can be an important con-
tribution to the positive entropic component, through the gain ofwhen compared to the pure substances. The N value suggests dif-
ferent equilibria between supramolecular systems in solution and
is in agreement with other results previously reported (Denadai
et al., 2007; De Sousa et al., 2008b).
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egression.
.2. Nuclear magnetic resonance studies
1H NMR  spectra of CD:PNT complexes at different molar ratios
1:1, 2:1, 3:1 and 4:1) were obtained in D2O solution and can be
iewed in the Supplementary Material (Fig. S1). Hydrogen chemi-
al shift for free PNT and its ICs at 1:1 and 2:1 molar ratio, as well as,
he chemical shifts variation (ı = ıPNT − ıCD:PNT) are summarized
n Table 1. Changes in PNT chemical shift were observed in pres-
nce of CD, when compared to the free PNT (Charpentier et al.,
008). These changes emphasize the interactions between the drug
nd the host molecules, as these shifts are associated with changes
n electron density due to the inclusion of PNT into the CD cav-
ty (Schneider et al., 1998; De Sousa et al., 2008c).  In spite of the
CD:PNT molar ratio (1:1 or 2:1), the most affected PNT hydrogens
re H1 of the aromatic moiety and the H5 aliphatic portion, sug-
esting a deep inclusion into the CD cavity. On the other hand, the
ess affected PNT hydrogens are H6 and H7 from isethionate group,
ndicating that this group does not participate in the inclusion pro-
ess. Additionally, the 1H NMR  spectra of CD:PNT at 3:1 and 4:1
howed no signiﬁcant difference from the 1H NMR  spectrum at 2:1,
ndicating that increasing the concentration above the 2:1 ratio did
ot lead to different superstructures in aqueous solution.
In addition to the analysis of the chemical shift variations,
uclear Overhauser Effect (NOE) experiments have been suc-
essfully applied to illustrate the through-space intermolecular
nteraction, these measurements being one of the most impor-
ant tools to conﬁrm the guest inclusion into the CD cavity. This
xperiment shows cross peak correlations among hydrogens indi-
ating interactions at a short distance (less than 5 A˚), (Schneider
t al., 1998; Gibaud et al., 2005) due to electromagnetic dipolar
oupling (Teixeira et al., 2006). The 2D ROESY spectrum of the
CD:PNT (1:1) supramolecular system is shown in Fig. 3, in which
everal cross peaks correlation are observed between PNT hydro-
ens and those from CD (H-3 and H-5 internal and H-2 and H-4
xternal). Fig. 3b and c shows the 2D ROESY contour map expan-
ions with the main cross peaks correlations between CD and
NT.(). (b) Final ﬁgure: (-) raw data, () subtracted curve of titration, (- - -) nonlinear
Cross peaks correlations between aromatic hydrogens (H1 and
H2) and the aliphatic protons (H4 and H5) of PNT with the H-3 and
H-5 internal hydrogens of the CD cavity, can be observed. More-
over, cross peak correlations between H6 and H7 from isethionate
and H-4 and H-2 from CD may  also be observed.
These results conﬁrm the deep inclusion of PNT into the CD
cavity, in which not only the aromatic moiety is included as
usual (Denadai et al., 2007; De Sousa et al., 2008a),  but also
the aliphatic chain is placed inside the CD cavity. In addi-
tion, the 2D ROESY results are in agreement with the 1H NMR
experiments, which indicated the interaction of the isethionate
group with CD outer side leading to the smaller chemical shifts
variations.
3.3. ESI-MS studies
ESI-MS in the positive mode (ESI(+)-MS) was  used to gain
insights about the supramolecular species distribution in aqueous
solutions at the following CD:PNT molar ratio 1:1, 2:1, 3:1, and
4:1, Fig. 4a, b, c and d, respectively. The ESI(+)-MS spectrum of the
free PNT is presented as Supplementary Material (Fig. S2).
Fig. 4a show ESI(+)-MS spectrum for CD:PNT (1:1), in which
the ion of m/z 341 was ascribed to the protonated form of PNT,
i.e. [PNT + H]+, whereas m/z 171 was attributed to the doubly-
charged species [PNT + 2H]2+. Moreover, the ions of m/z 467 and
1059 were attributed as the protonated ions formed between PNT
and isethionate (ISO), i.e. [PNT + ISO + H]+ and [2PNT + 3ISO + H]+,
respectively. These PNT ions were observed in the ESI-MS spectrum
of PNT (Fig. S2), conﬁrming that free PNT molecules are in equi-
librium with its ICs in aqueous solution. Moreover, these results
indicated that the free PNT molecule is able to self-assemble, which
was also observed in the PNT dilution curve by ITC. In addition to
the free PNT ions, ICs were also observed in the ESI-MS spectrum of
the CD:PNT (1:1) system. Among these ions, there are observed
those with m/z 1601, 738, and 1305. These ions were attributed as
the protonated forms of the following ICs: [CD + PNT + ISO + H]+,
[CD + PNT + 2H]2+, and [2CD + PNT + 2H]2+, respectively. At the
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ig. 3. (a) NMR  2D ROESY contour map  (at 400 MHz) in D2O of CD:PNT (1:1) mola
nd  (c) at  1.90–1.45.
olar ratio of (1:1), the PNT counter ion (ISO) was shifted from the
olecule coordination sphere, when PNT interacted with the CD,
robably with its cavity forming ICs. This phenomenon is empha-
ized when the CD:PNT (2:1) complex was formed in solution and
SO counter ion is not observed in the supramolecular structure,
orroborating the NMR  experiments. The 1:1 supramolecular com-
+lex detected in this experiment was [CD + PNT + ISO + H] and
CD + PNT + 2H]2+, in which the CD also shifted the counter ion.
he double charge molecular ions for CD:PNT (1:1) system can be
een clearly in Fig. S3 of the Supplementary Material.
able 1
H chemical shifts (at 400 MHz) of PNT protons of pure drug and in presence of CD usin
Proton ı PNT ıCD:PNT (1:1) ı 1:1
H-1 7.60 7.77 −0.173
H-2  6.98 7.07 −0.095
H-3  4.01 4.11 −0.099
H-4  1.73 1.84 −0.109
H-5  1.49 1.63 −0.143
H-6  3.01 3.10 −0.083
H-7 3.81 3.89 −0.081
ı  = ıPNT − ıCD:PNT. Negative values indicate downﬁeld shift. and expansion of NMR  2D ROESY spectra of the CD:PNT (1:1): (b) at  7.80–6.50
Fig. 4b displays the ESI-MS CD:PNT at 2:1 molar ratio, in
which the same ion peaks of Fig. 4a are presented. Moreover,
the relative intensity of the m/z 1305 ion ([2CD + PNT + 2H]2+)
is higher than that observed in Fig. 4a. This result indicates that
the higher concentration of CD induces the formation of greater
amounts of this superstructure in solution. Additionally, the rela-
+tive amount of [CD + PNT + ISO + H] is inferior to that observed
in Fig. 4a. This trend is conﬁrmed by the results from ESI-MS
spectra at 3:1 and 4:1 CD:PNT solutions, Fig. 4c and d respec-
tively. Increasing the CD concentration above 2:1 ratio, did
g D2O and ı values.
/(CD:PNT) ıCD:PNT (2:1) ı 2:1/(CD:PNT)
 7.78 −0.180
 7.10 −0.125
 4.14 −0.126
 1.86 −0.128
 1.63 −0.139
 3.10 −0.082
 3.89 −0.080
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Fig. 4. ESI(+)-MS of an aqueous solution: (a) of -cyclodextrin (CD) and pentamidine isothionate (PNT ISO) in a molar proportion of 1:1, (b) CD:PNT 2:1, (c) CD:PNT 3:1
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dnd  (d) CD:PNT 4:1.
ot induced superstructures at 3:1, 4:1 or higher ratios of CD
PNT. These results indicate that the most probable supramolecular
pecies in equilibrium in aqueous solution are: free PNT molecule
nd its ICs at 1:1 and 2:1 molar ratio. This equilibrium is in
ccordance with those results obtained by ITC, in which a frac-
ional (N) was observed. Moreover, when CD concentration is
ncreased from 1:1 molar ratio to 4:1, the relative amount of free
NT molecules such as [PNT + ISO + H]+ and [2PNT + 3ISO + H]+ are
educed in solution, suggesting that more supramolecular com-
lexes (CD:PNT at 1:1 and 2:1) are formed under the experimental
onditions.
.4. Fourier transform infrared spectroscopy (FTIR)
Infrared spectroscopy (FTIR) was used in order to character-
ze the ICs and associated with other techniques to suggest the
nclusion process in the solid state. The vibrational spectra in the
nfrared region for the CD, PNT, CD:PNT (1:1) and PM-CD:PNT
1:1) are shown in Fig. S4 in the Supplementary Material. Ana-
yzing the CD FTIR spectrum, its characteristics bands can be
bserved in accordance with the literature (Egyed, 1990; Teixeira
t al., 2006; Rezende et al., 2009). The absorption spectrum in
he infrared region for PNT exhibits well-deﬁned bands and some
ibrational modes can be highlighted, including the band observed
t 3396 cm−1 which is attributed to the (OH) of the hydroxyl
roup of the isethionate counter ion and the bands observed at
133 and 2952 cm−1, respectively attributed to stretching of ami-
ine (N H) and aliphatic (C H) groups. The bands observed at 1680and 1488 cm−1 are respectively assigned to (CO) and (CC/CN), as
described in the literature (Schmitz and Hubner, 1995).
Comparative analysis of the CD:PNT (1:1) compound absorp-
tion spectrum (FTIR) with its precursors CD and PNT demon-
strated that PNT bands changed after interaction with the CD,
reducing the number of vibrational modes of free PNT indicating
the lower mobility of PNT upon inclusion. In contrast, no change
or reduction in the host and guest bands were observed in the PM-
CD:PNT (1:1) spectrum, indicating that PNT is not interacting with
CD in solid state for this system.
3.5. Thermal analysis (TG and DTA)
TG and DTA curves for the CD:PNT (1:1), PM-CD:PNT (1:1),
CD and PNT, are shown respectively in Figs. S5 and S6 in the
Supplementary Material. The thermal proﬁle of the CD is in accor-
dance with the literature (Yilmaz et al., 1995). Thermal analysis of
the drug PNT can be seen in Fig. S5 (a) and shows a signiﬁcant
loss of mass in the range of 300–335 ◦C, attributed to its thermod-
egradation. It is observed in the DTA curve of the drug PNT, ﬁve
endothermic events, including a peak at 192 ◦C corresponding to
its melting point.
Thermogravimetric analysis for the CD:PNT (1:1) indicated
its higher thermal stability compared to the precursor and PM-
CD:PNT (1:1). In the TG curve of compound CD:PNT (1:1) a
weight loss of 7% is observed and was attributed to the loss of water
molecules. The compound is stable up to 230 ◦C, where a decom-
position stage begins and continues up to 246 ◦C with a mass loss
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Fig. 6. Parasite burden in the liver (A) and spleen (B) of BALB/c mice infected with L.
(L.) infantum chagasi. CD:PNT (1:1) dose 145 mg/kg (contains 50 mg/kg of PNT and
95  mg/kg/day of CD); free PNT dose 50 mg/kg, free CD dose 95 mg/kg/day; saline
(negative control); GLU, commercial antimonial drug Glucantime® given intraperi-
toneally at 80 mg Sb/kg/day (positive control). Parasite burden was  determined byFig. 5. SEM micrographs of (a) PNT at 30× and (b) CD:PNT (1:1) at 700×.
f about 28%, which is related to the start of CD thermodecom-
osition. Then, there is a third weight loss of 20% relative to the
eginning of PNT thermodecomposition and at 340 ◦C there is 42%
f residue. In the DTA curves, it is observed that the physical mixture
hermal behavior is the sum of the thermal behaviors of free pre-
ursors CD and PNT, unlike the inclusion complex CD:PNT (1:1).
he DTA curve of the compound CD:PNT (1:1) does not show the
ndothermic peak of PNT fusion at 192 ◦C, unlike the physical mix-
ure DTA curve in which endothermic events at 96, 192, 243 and
40 ◦C are observed. Moreover, the presence of only two events
n the CD:PNT (1:1) DTA curve, indicates a stronger interaction
etween the macromolecules CD and drug and suggests the exis-
ence of a complex between CD and PNT, indicating the existence
f the inclusion compound CD:PNT (1:1) in the solid state.
In addition, the thermal behavior of the CD:PNT (2:1), CD:PNT
3:1) and CD:PNT (4:1) supramolecular systems did not differ
rom those observed at 1:1 molar ratio, indicating that the CD
oncentration was not able to modify the PNT thermal stability.
.6. Scanning electron microscopy (SEM)
Fig. 5 shows SEM images obtained for the free drug and the
C at CD:PNT 1:1 molar ratio. Morphological analysis of the PNT
ndicates an amorphous proﬁle and SEM images for the system
CD:PNT (1:1), Fig. 5b, exhibits a lamellar aspect and suggests that
he IC is homogeneous in solid state. These lamellar forms are due
o the sample freezing stage in liquid nitrogen, which anterior to
he freeze drying process and the continuous drying process under
acuum.Based on the results obtained in aqueous solution and in the
olid state, PNT inclusion into the CD cavity can be conﬁrmed thus,
n vivo experiments can be designed and PNT activity compared in
he presence or absence of the host molecule administrated orally.limiting dilution assay. Data are shown as means ± SE (n = 7–10). The asterisks indi-
cates that differences are statistically signiﬁcant (*p < 0.05, **p < 0.001, ***p  < 0.0001)
according to Kruskal–Wallis test followed by Bonferroni post-test.
3.7. In vivo experiments
The results of in vivo experiments are shown in Fig. 6. Brieﬂy,
BALB/c mice were infected with L. infantum chagasi after treatment
with CD:PNT (1:1), free PNT, saline and both control experiments
by oral route. From the analysis results, it was observed that both in
liver and spleen showed no difference between the treated group
with PNT at a dose of 50 mg/kg compared to the control group
treated with saline solution, as expected since the said drug does
not comprise an orally. However, as can be seen from the data,
CD:PNT (1:1) promoted a signiﬁcant reduction of the parasite
load in both organs, when compared to those in the control group
treated with saline. The efﬁcacy of orally-active CD:PNT (1:1)
was similar to that of the ﬁrst-line glucantime treatment given
parenterally, being these results in contrast with those obtained
with orally administered PNT which did not induce a signiﬁcant
reduction of the parasite burden. Furthermore, the CD:PNT (1:1)
inclusion complex promoted a signiﬁcantly lower parasite load in
the spleen when compared to free PNT. The IC showed greater
reduction of parasitemia in the liver in relation to the spleen.
The results, when considered in context, indicate enhanced
oral activity of the CD:PNT (1:1) when compared to free PNT in
the murine model of visceral leishmaniasis and showed that the
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ncapsulation process of PNT with CD alter the absorption char-
cteristics of such drug, which makes this method a alternative
romising for the treatment of leishmaniasis.
. Conclusions
This work was carried out to gain a more complete compre-
ension concerning the non covalent interactions between PNT
nd CD in aqueous solutions and the supramolecular struc-
ure of these ICs. Based on the results obtained from ITC, ESI-MS
nd NMR, sophisticated techniques to investigate the interactions
n host–guest systems using CDs in aqueous solutions, we  have
emonstrated the PNT inclusion into the host cavity. ITC experi-
ents allowed us to identify the thermodynamic parameters of the
nclusion process and the stoichiometric coefﬁcient indicated the
quilibrium of more than one supramolecular system in aqueous
olution. This observation was also veriﬁed through ESI-MS spectra
f the ICs at 1:1, 2:1, 3:1 and 4:1 molar ratios. An interesting fact is
hat the IC at CD:PNT (2:1) ratio showed a higher relative abun-
ance compared to CD:PNT (1:1). Additionally, molecular ions
eferring to the complex in the proportions 3:1 and 4:1 were not
bserved in the spectra.
Changes in chemical shift between free PNT and ICs hydro-
en atoms, showed that increasing the CD ratio in CD:PNT
2:1) in the inclusion complex, does not alter the structure of
he supramolecular system. 2D ROESY spectra allowed us to infer
he depth inclusion of PNT in CD cavity, since correlations were
bserved between both aromatic and aliphatic PNT hydrogen with
CD internal hydrogens. In this manner, all results suggest the for-
ation of a CD:PNT (1:1) supramolecular complex in equilibrium
ith a CD:PNT (2:1) system, which suggests the formation of
uperstructures in solution. Moreover, the inclusion process was
onﬁrmed in the solid state using FTIR, TG/DTA and SEM.
Additionally, the biological assays showed a signiﬁcant change
n the characteristics of PNT in the presence of CD, since the for-
ulation administered in vivo in mice by gavage presented better
ral activity, in contrast to free drug.
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